GPI pulse™ International Reference Pricing is a dynamic value, price, and access analytics platform, utilising powerful algorithms to combine multiple data streams in a way that will give you unique insight into the full market access journey. GPI pulse™ is a dynamic value, price, and access analytics platform, utilising powerful algorithms to combine multiple data streams in a way that will give you unique insight into the full market access journey. This powerful platform is designed to be used as part of GPI’s comprehensive solution for pricing and market access strategy, but can also be leveraged to rapidly extract customised sets of analysis-ready data. To complement the price, reimbursement, and treatment cost data, GPI closely track policy events, regulatory and legislative updates, including international reference pricing changes, that could influence the price and reimbursement landscape. Each market has a set of formal and informal reference pricing rules which GPI collects from a range of public sources, primarily legislation. Use cases: - Clearly identify reference and reference countries for each market with our IRP matrix - Power your IRP simulations with up-to-date international reference pricing rules - Remove the burden of tracking IRP globally with timely updates - Understand formal and informal reference rules and the relationship between stakeholders and markets GPI continually invest in technology, taxonomy, and quality assurance, to ensure our data is the gold-standard in terms of accuracy, granularity, and timeliness. GPI pulse™ supports the full spectrum of biopharma clients, from top tier pharma to clinical stage biotech. The analytics tools within GPI pulse™ are built specifically with pricing, market access, and commercial strategy teams in mind. FREE DATA SAMPLES AVAILABLE: - Pricing - Cost of Treatment - Reimbursement and HTA